CTI Breast Imaging System Panel Review Falters On Retrospective Analysis

Computerized Thermal Imaging, Inc.'s "post-hoc," retrospective analysis of breast masses viewed with the BCS 2100 thermal breast imaging system failed to convince FDA's Radiological Devices Advisory Panel of the device's effectiveness